Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression
- 740 Downloads
Human gliomas represent the most common type of intracranial tumors, with highest morbidity and mortality. They are characterized by excessive invasiveness and cell proliferation while their unclear boundaries predispose to tumor recurrence soon after conventional treatment. Elucidation of the molecular mechanisms implicated in their development and/or treatment resistance is highly demanded. The high-mobility group box 1 (HMGB1) protein, a highly conserved nuclear protein that functions as a chromatin-binding factor, facilitating nucleosome stabilization and regulating gene transcription, has been implicated in glioma formation and progression. Extracellular released HMGB1 binds to high-affinity receptors, including the receptor for advanced glycation end-products (RAGE) and toll-like receptor (TLR)-2, TLR-4, and TLR-9. Upon receptor binding, HMGB1 triggers the activation of key signaling pathways and immune responses, involved in the regulation of cell growth, differentiation, motility, and apoptosis. Based on the type of receptor and/or cell, HMGB1 is capable to promote oncogenesis or suppress tumor growth, thus affecting treatment efficacy. Herein, we discuss recent evidence implicating HMGB1 in glioma cell differentiation, proliferation, and metastasis with both clinical and prognostic significance. In addition, potential therapeutic approaches to target this protein in order to reduce chemoresistance of glioma cells are also addressed.
KeywordsHMGB1 Gliomas Brain tumors RAGE TLRs Immunotherapy
E. Angelopoulou is supported by a scholarship from “Alexander S. Onassis Public Benefit Foundation,” Greece.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 35.Karaayvaz M, Zhai H, Ju J (2013) miR-129 promotes apoptosis and enhances chemosensitivity to 5.doi: 10.1038/cddis.2013.193
- 44.Hudson BI, Kalea AZ, Del Mar AM, Harja E, Boulanger E, D’Agati V, Schmidt AM (2008) Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem 283:34457–34468CrossRefPubMedPubMedCentralGoogle Scholar
- 48.Ordonez R, Carbajo-Pescador S, Prieto-Dominguez N, Garcia-Palomo A, Gonzalez-Gallego J, Mauriz JL (2014) Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells. J Pineal Res 56:20–30CrossRefPubMedGoogle Scholar
- 58.Shin JH, Kim ID, Kim SW et al (2014) Ethyl pyruvate inhibits HMGB1 phosphorylation and release by chelating calcium. Mol Med 20:649–657Google Scholar